Group 1 - The high-pressure oxygen chamber concept declined by 2.26%, ranking among the top declines in concept sectors, with companies like Aoyang Health, International Medicine, and Weiao Co., Ltd. experiencing significant drops [1] - The main funds in the high-pressure oxygen chamber concept saw a net outflow of 363 million yuan, with seven stocks experiencing net outflows, led by Innovation Medical with a net outflow of 308 million yuan [2] - Other companies with notable net outflows include Aoyang Health, Dahu Co., Ltd., and Yinkang Life, with net outflows of 27.01 million yuan, 8.53 million yuan, and 6.79 million yuan respectively [2] Group 2 - The top gainers in concept sectors included the military equipment restructuring concept, which rose by 3.51%, and PCB concept, which increased by 3.29% [2] - The high-pressure oxygen chamber concept was among the sectors with the largest declines, alongside glyphosate and rare earth permanent magnets, which fell by 2.82% and 2.57% respectively [2] - The trading volume for the high-pressure oxygen chamber concept stocks showed varying turnover rates, with Innovation Medical at 36.76% and Aoyang Health at 17.53% [2]

Core Points - Samsung Medical's stock closed at 22.34 yuan on June 13, 2025, down 0.18% from the previous week [1] - The company's market capitalization is currently 31.522 billion yuan, ranking 8th out of 120 in the power equipment sector and 454th out of 5,150 in the A-share market [1] Company Announcements - Samsung Medical announced a change in the purpose of repurchased shares, converting 5,755,371 shares for cancellation and reduction of registered capital, resulting in a new total share count of 1,405,251,200 shares [1] - The company held its 2025 first extraordinary general meeting, where the resolution to change the purpose of repurchased shares was approved with 99.9127% of votes in favor [2] - The company notified creditors of their rights to claim debts or request guarantees within specified timeframes following the announcement [1]

Meeting Details - The shareholder meeting was held on June 13, 2025, at the AUX Central Building, No. 757, Rili Middle Road, Shounan Street, Yinzhou District, Ningbo [1] - The total proportion of shares held by attending ordinary shareholders and preferred shareholders with restored voting rights was 50.5697% [1] - The meeting was convened by the board of directors and chaired by Ms. Shen Guoying, using a combination of on-site and online voting methods, complying with the Company Law and the Articles of Association [1] Voting Results - The voting results showed that 707,103,439 A-shares (99.9127%) were in favor, with 498,907 votes (0.0704%) against, and 118,900 votes (0.0169%) abstaining [2] - The proposal regarding the change of part of the repurchase share usage and reduction of the company's registered capital was passed [2] Legal Verification - Lawyers Li Bo and Li Qinzhi confirmed that the procedures for convening and holding the 2025 first extraordinary general meeting of shareholders complied with relevant laws, regulations, and the Articles of Association, making the voting results valid [2]

Group 1 - The company has decided to change the purpose of 5,755,371 repurchased shares from employee stock ownership plans to cancellation and reduction of registered capital, aiming to optimize shareholder returns and enhance investor confidence [1][2] - Following the cancellation, the total share capital is expected to decrease from 1,411,006,571 shares to 1,405,251,200 shares, and the registered capital will reduce from 1,411,006,571 yuan to 1,405,251,200 yuan [2] - The company is notifying creditors that they have 30 days from receiving the notice, or 45 days from the announcement date if not notified, to claim their debts or request guarantees [2][3] Group 2 - Creditors must provide valid documentation to prove their claims, including contracts and agreements, and must follow specific procedures for debt declaration [3] - The company has outlined the office hours for creditors to submit their claims, which are from 8:30 AM to 12:00 PM and 1:30 PM to 6:00 PM on weekdays [3]

重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 6 月 13 日 (二)股东会召开的地点：宁波市鄞州区首南街道日丽中路 757 号奥克斯中央大厦 25 楼会议室 证券代码：601567 证券简称：三星医疗 公告编号：临2025-047 宁波三星医疗电气股份有限公司 2025年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 审议结果：通过 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 925 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 707,721,246 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 50.5697 | 注：上表中公司有表决权股份总数不含公司回购账户中的股份数，本次已剔除。 (四)表决方式是否符合《公司法》及《公司章程》的规定，股东会主持情况等。 本次股东会由公司董事 ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-048 宁波三星医疗电气股份有限公司 关于注销部分回购股份减少注册资本通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、通知债权人的原由 宁波三星医疗电气股份有限公司（以下简称"公司"）于 2025 年 5 月 28 日召 开第六届董事会第二十三次会议，审议通过了《关于变更部分回购股份用途为注 销并减少公司注册资本的议案》。基于对公司未来发展的信心和对公司长期价值 的认同，为切实优化股东投资回报，增强投资者的投资信心，公司拟将存放于股 份回购专用证券账户中已回购尚未使用的 5,755,371 股股份用途进行变更，由"用 于实施员工持股计划或股权激励计划"变更为"用于注销并减少公司注册资本"。 该事项已经公司于 2025 年 6 月 13 日召开的 2025 年第一次临时股东会审议通过。 详见 2025 年 5 月 29 日、2025 年 6 月 14 日刊登于上海证券交易所网站 （http://www.sse.com.cn）及《上海证券报》 ...

上海市锦天城律师事务所 关于宁波三星医疗电气股份有限公司 2025 年第一次临时股东会的 法律意见书 锦 天 斌 律师事务 所 ALLBRIGHT LAW OFFICES 地址：上海市浦东新区银城中路 501 号上海中心大厦 11/12 楼 电话：021-20511000 传真: 021-20511999 邮编： 200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于宁波三星医疗电气股份有限公司 2025 年第一次临时股东会的 法律意见书 致:宁波三星医疗电气股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受宁波三星医疗电气股份有 限公司（以下简称"公司"）委托,就公司召开 2025 年第一次临时股东会（以下简 称"本次股东会"）的有关事宜,根据《中华人民共和国公司法》（以下简称《公 司法》）《上市公司股东会规则》等法律、法规、规章和其他规范性文件以及《宁 波三星医疗电气股份有限公司章程》（以下简称《公司章程》）的有关规定，出具 本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务管 理办法》和《律师事务所证券法律业务执业规则(试行)》等规定,严 ...

Group 1 - The high-pressure oxygen chamber concept increased by 1.54%, ranking 6th among concept sectors, with five stocks rising, including Aoyang Health, which hit the daily limit, and Yingkang Life, Jinling Pharmaceutical, and International Medicine showing gains of 4.30%, 1.70%, and 0.58% respectively [1][2] - The main capital inflow into the high-pressure oxygen chamber concept was 0.52 billion yuan, with Aoyang Health receiving the highest net inflow of 68.73 million yuan, followed by Yingkang Life and Samsung Medical with net inflows of 11.24 million yuan and 9.36 million yuan respectively [2][3] - Aoyang Health, Yingkang Life, and Tiedean Heavy Industry had the highest net inflow ratios of 7.40%, 3.64%, and 3.00% respectively, indicating strong investor interest [3][4] Group 2 - The top-performing stocks in the high-pressure oxygen chamber concept included Aoyang Health with a daily increase of 10.12% and a turnover rate of 26.84%, while other notable stocks included Yingkang Life and Samsung Medical with increases of 4.30% and 0.17% respectively [3][4] - Stocks that experienced declines included Innovative Medical, Tiedean Heavy Industry, and Weiao Co., with decreases of 1.56%, 0.74%, and 0.68% respectively, indicating some volatility within the sector [1][4]

上海市锦天城律师事务所 关于宁波三星医疗电气股份有限公司 差异化分红事项的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 为出具本法律意见书，本所及本所律师审查了公司提供的本次差异化分红的 相关文件，就有关事项向公司进行了必要的询问。本所律师依据本法律意见书出 具日以前已经发生或存在的事实并基于对现行法律、法规和规范性文件的理解发 表法律意见。 本法律意见书仅就本次差异化分红所涉及的法律问题发表法律意见，并不对 有关会计、审计、验资等专业事项和报告发表意见。本法律意见书中对有关审计 报告、验资报告中某些数据和结论的引述，并不意味着本所对这些数据、结论的 真实性和准确性做出任何明示或默示的保证。对于该等数据、报告的内容，本所 以及本所律师并不具备核查和作出评价的适当资格。 基于上述，本所根据有关法律、法规和中国证监会有关规定的要求，按照律 师行业公认的业务标准、道德规范和勤勉尽责精神，现出具法律意见如下： 一、本次差异化分红的原因 上 ...

证券代码：601567 证券简称：三星医疗 公告编号：临2025-046 宁波三星医疗电气股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.89元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/10 | － | 2025/6/11 | 2025/6/11 | （1）本次差异化分红方案 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东（回 购专用证券账户中的股份除外）。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等有关 规定，公司回购专用账户中的股份，不享有利润分配、公积金转增股本等权利。 基于此，公司存放于回购专用证券账户中的股份将不参与本次利润分配。 3. 差 ...